Anti-MOT10/ SLC16A10/ MCT10 monoclonal antibody

Anti-MOT10/ SLC16A10/ MCT10 antibody for FACS & in-vivo assay

Target products collectionGo to SLC16A10/SLC16A10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1541-Ab-1/ GM-Tg-hg-MP1541-Ab-2Anti-Human SLC16A10 monoclonal antibodyHuman
GM-Tg-rg-MP1541-Ab-1/ GM-Tg-rg-MP1541-Ab-2Anti-Rat SLC16A10 monoclonal antibodyRat
GM-Tg-mg-MP1541-Ab-1/ GM-Tg-mg-MP1541-Ab-2Anti-Mouse SLC16A10 monoclonal antibodyMouse
GM-Tg-cynog-MP1541-Ab-1/ GM-Tg-cynog-MP1541-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC16A10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1541-Ab-1/ GM-Tg-felg-MP1541-Ab-2Anti-Feline SLC16A10 monoclonal antibodyFeline
GM-Tg-cang-MP1541-Ab-1/ GM-Tg-cang-MP1541-Ab-2Anti-Canine SLC16A10 monoclonal antibodyCanine
GM-Tg-bovg-MP1541-Ab-1/ GM-Tg-bovg-MP1541-Ab-2Anti-Bovine SLC16A10 monoclonal antibodyBovine
GM-Tg-equg-MP1541-Ab-1/ GM-Tg-equg-MP1541-Ab-2Anti-Equine SLC16A10 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1541-Ab-1/ GM-Tg-hg-MP1541-Ab-2; GM-Tg-rg-MP1541-Ab-1/ GM-Tg-rg-MP1541-Ab-2;
GM-Tg-mg-MP1541-Ab-1/ GM-Tg-mg-MP1541-Ab-2; GM-Tg-cynog-MP1541-Ab-1/ GM-Tg-cynog-MP1541-Ab-2;
GM-Tg-felg-MP1541-Ab-1/ GM-Tg-felg-MP1541-Ab-2; GM-Tg-cang-MP1541-Ab-1/ GM-Tg-cang-MP1541-Ab-2;
GM-Tg-bovg-MP1541-Ab-1/ GM-Tg-bovg-MP1541-Ab-2; GM-Tg-equg-MP1541-Ab-1/ GM-Tg-equg-MP1541-Ab-2
Products NameAnti-SLC16A10 monoclonal antibody
Formatmab
Target NameSLC16A10
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC16A10 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species MOT10/ SLC16A10/ MCT10 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm003798mouse Slc16a10 Lentivirus plasmid
    ORF Viral VectorvGMLPm003798mouse Slc16a10 Lentivirus particle


    Target information

    Target IDGM-MP1541
    Target NameSLC16A10
    Gene ID117247,72472,170566,696132,612335,101087159,541240,100072381
    Gene Symbol and Synonyms2610103N14Rik,9830169E08,MCT10,PRO0813,SLC16A10,TAT1
    Uniprot AccessionQ8TF71,Q91Y77
    Uniprot Entry NameMOT10_HUMAN,MOT10_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112394
    Target ClassificationN/A

    The target: SLC16A10, gene name: SLC16A10, also named as MCT10, PRO0813, TAT1. SLC16A10 is a member of a family of plasma membrane amino acid transporters that mediate the Na(+)-independent transport of aromatic amino acids across the plasma membrane.[supplied by OMIM, Apr 2004].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.